Literature DB >> 17181175

N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors.

Päivi H Kiviranta1, Jukka Leppänen, Sergiy Kyrylenko, Heikki S Salo, Maija Lahtela-Kakkonen, Anu J Tervo, Carsten Wittekindt, Tiina Suuronen, Erkki Kuusisto, Tomi Järvinen, Antero Salminen, Antti Poso, Erik A A Wallén.   

Abstract

A series of N,N'-bisbenzylidenebenzene-1,4-diamine and N,N'-bisbenzylidenenaphthalene-1,4-diamine derivatives were synthesized as inhibitors for human sirtuin type 2 (SIRT2). The design of the new compounds was based on two earlier reported hits from molecular modeling and virtual screening. The most potent compound was N,N'-bis(2-hydroxybenzylidene)benzene-1,4-diamine, which was equipotent with the most potent hit compound and well-known SIRT2 inhibitor sirtinol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17181175     DOI: 10.1021/jm060566j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2).

Authors:  Soo Hyuk Choi; Luisa Quinti; Aleksey G Kazantsev; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2012-03-03       Impact factor: 2.823

2.  Design of a novel nucleoside analog as potent inhibitor of the NAD dependent deacetylase, SIRT2.

Authors:  Padavattan Sivaraman; Suresh Mattegunta; Gottumukkala V Subbaraju; Chava Satyanarayana; Balasundaram Padmanabhan
Journal:  Syst Synth Biol       Date:  2011-02-23

3.  Identification and characterization of novel sirtuin inhibitor scaffolds.

Authors:  Brandi D Sanders; Brittany Jackson; Michael Brent; Alexander M Taylor; Weiwei Dang; Shelley L Berger; Stuart L Schreiber; Konrad Howitz; Ronen Marmorstein
Journal:  Bioorg Med Chem       Date:  2009-08-03       Impact factor: 3.641

Review 4.  Rejuvenating sirtuins: the rise of a new family of cancer drug targets.

Authors:  Santina Bruzzone; Marco Daniele Parenti; Alessia Grozio; Alberto Ballestrero; Inga Bauer; Alberto Del Rio; Alessio Nencioni
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Inhibition of the NAD-dependent protein deacetylase SIRT2 induces granulocytic differentiation in human leukemia cells.

Authors:  Yoshitaka Sunami; Marito Araki; Yumi Hironaka; Soji Morishita; Masaki Kobayashi; Ei Leen Liew; Yoko Edahiro; Miyuki Tsutsui; Akimichi Ohsaka; Norio Komatsu
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.